pcDNA3.3_CoV2_D18 Citations (1)
Originally described in: Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model.Rogers TF, Zhao F, Huang D, Beutler N, Burns A, He WT, Limbo O, Smith C, Song G, Woehl J, Yang L, Abbott RK, Callaghan S, Garcia E, Hurtado J, Parren M, Peng L, Ramirez S, Ricketts J, Ricciardi MJ, Rawlings SA, Wu NC, Yuan M, Smith DM, Nemazee D, Teijaro JR, Voss JE, Wilson IA, Andrabi R, Briney B, Landais E, Sok D, Jardine JG, Burton DR Science. 2020 Aug 21;369(6506):956-963. doi: 10.1126/science.abc7520. Epub 2020 Jun 15. PubMed Journal
Articles Citing pcDNA3.3_CoV2_D18
| Articles |
|---|
| Fluoxetine and Sertraline Potently Neutralize the Replication of Distinct SARS-CoV-2 Variants. Thummler L, Beckmann N, Sehl C, Soddemann M, Brass P, Bormann M, Brochhagen L, Elsner C, Hoertel N, Cougoule C, Ciesek S, Widera M, Dittmer U, Lindemann M, Horn PA, Witzke O, Kadow S, Kamler M, Gulbins E, Becker KA, Krawczyk A. Viruses. 2024 Mar 30;16(4):545. doi: 10.3390/v16040545. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.